357 related articles for article (PubMed ID: 15194787)
1. Sequencing-based detection of low-frequency human immunodeficiency virus type 1 drug-resistant mutants by an RNA/DNA heteroduplex generator-tracking assay.
Kapoor A; Jones M; Shafer RW; Rhee SY; Kazanjian P; Delwart EL
J Virol; 2004 Jul; 78(13):7112-23. PubMed ID: 15194787
[TBL] [Abstract][Full Text] [Related]
2. Comparison of DNA sequencing and a line probe assay for detection of human immunodeficiency virus type 1 drug resistance mutations in patients failing highly active antiretroviral therapy.
Servais J; Lambert C; Fontaine E; Plesséria JM; Robert I; Arendt V; Staub T; Schneider F; Hemmer R; Burtonboy G; Schmit JC
J Clin Microbiol; 2001 Feb; 39(2):454-9. PubMed ID: 11158089
[TBL] [Abstract][Full Text] [Related]
3. Identification and recovery of minor HIV-1 variants using the heteroduplex tracking assay and biotinylated probes.
Schnell G; Ince WL; Swanstrom R
Nucleic Acids Res; 2008 Dec; 36(22):e146. PubMed ID: 18948297
[TBL] [Abstract][Full Text] [Related]
4. Population genetic analysis of the protease locus of human immunodeficiency virus type 1 quasispecies undergoing drug selection, using a denaturing gradient-heteroduplex tracking assay.
Doukhan L; Delwart E
J Virol; 2001 Jul; 75(14):6729-36. PubMed ID: 11413343
[TBL] [Abstract][Full Text] [Related]
5. Monitoring resistance to human immunodeficiency virus type 1 protease inhibitors by pyrosequencing.
O'Meara D; Wilbe K; Leitner T; Hejdeman B; Albert J; Lundeberg J
J Clin Microbiol; 2001 Feb; 39(2):464-73. PubMed ID: 11158091
[TBL] [Abstract][Full Text] [Related]
6. A multiple-site-specific heteroduplex tracking assay as a tool for the study of viral population dynamics.
Resch W; Parkin N; Stuelke EL; Watkins T; Swanstrom R
Proc Natl Acad Sci U S A; 2001 Jan; 98(1):176-81. PubMed ID: 11120887
[TBL] [Abstract][Full Text] [Related]
7. Evidence for preferential genotyping of a minority human immunodeficiency virus population due to primer-template mismatching during PCR-based amplification.
Martinez-Picado J; Morales-Lopetegi K; Villena C; Gutiérrez C; Izquierdo N; Marfil S; Clotet B; Ruiz L
J Clin Microbiol; 2005 Jan; 43(1):436-8. PubMed ID: 15635008
[TBL] [Abstract][Full Text] [Related]
8. A novel substrate-based HIV-1 protease inhibitor drug resistance mechanism.
Nijhuis M; van Maarseveen NM; Lastere S; Schipper P; Coakley E; Glass B; Rovenska M; de Jong D; Chappey C; Goedegebuure IW; Heilek-Snyder G; Dulude D; Cammack N; Brakier-Gingras L; Konvalinka J; Parkin N; Kräusslich HG; Brun-Vezinet F; Boucher CA
PLoS Med; 2007 Jan; 4(1):e36. PubMed ID: 17227139
[TBL] [Abstract][Full Text] [Related]
9. Transmission of HIV-1 minority-resistant variants and response to first-line antiretroviral therapy.
Peuchant O; Thiébaut R; Capdepont S; Lavignolle-Aurillac V; Neau D; Morlat P; Dabis F; Fleury H; Masquelier B;
AIDS; 2008 Jul; 22(12):1417-23. PubMed ID: 18614864
[TBL] [Abstract][Full Text] [Related]
10. Natural residues versus antiretroviral drug-selected mutations in HIV type 1 group O reverse transcriptase and protease related to virological drug failure in vivo.
de Baar MP; Janssens W; de Ronde A; Fransen K; Colebunders R; Kestens L; van der Groen G; Goudsmit J
AIDS Res Hum Retroviruses; 2000 Sep; 16(14):1385-94. PubMed ID: 11018858
[TBL] [Abstract][Full Text] [Related]
11. Antiretroviral genotypic resistance in plasma RNA and whole blood DNA in HIV-1 infected patients failing HAART.
Saracino A; Gianotti N; Marangi M; Cibelli DC; Galli A; Punzi G; Monno L; Lazzarin A; Angarano G;
J Med Virol; 2008 Oct; 80(10):1695-706. PubMed ID: 18712823
[TBL] [Abstract][Full Text] [Related]
12. Rapid detection of drug resistant HIV -1 to reverse transcriptase and protease inhibitors in HIV-infected patients receiving highly active antiretroviral therapies.
Yu M; Kabat W; Wang J
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2000 Dec; 14(4):325-9. PubMed ID: 11471017
[TBL] [Abstract][Full Text] [Related]
13. HIV-1 drug resistance in variants from the female genital tract and plasma.
Kemal KS; Burger H; Mayers D; Anastos K; Foley B; Kitchen C; Huggins P; Schroeder T; Picchio G; Back S; Gao W; Meyer WA; Weiser B
J Infect Dis; 2007 Feb; 195(4):535-45. PubMed ID: 17230413
[TBL] [Abstract][Full Text] [Related]
14. Evolution of human immunodeficiency virus type 1 populations after resumption of therapy following treatment interruption and shift in resistance genotype.
Izopet J; Souyris C; Hance A; Sandres-Sauné K; Alvarez M; Pasquier C; Clavel F; Puel J; Massip P
J Infect Dis; 2002 May; 185(10):1506-10. PubMed ID: 11992288
[TBL] [Abstract][Full Text] [Related]
15. Zero prevalence of primary drug resistance-associated mutations to protease inhibitors in HIV-1 drug-naive patients in and around Aligarh, India.
Azam M; Malik A; Rizvi M; Rai A
J Infect Dev Ctries; 2014 Jan; 8(1):79-85. PubMed ID: 24423716
[TBL] [Abstract][Full Text] [Related]
16. A sensitive in-house RT-PCR genotyping system for combined detection of plasma HIV-1 and assessment of drug resistance.
Steegen K; Demecheleer E; De Cabooter N; Nges D; Temmerman M; Ndumbe P; Mandaliya K; Plum J; Verhofstede C
J Virol Methods; 2006 May; 133(2):137-45. PubMed ID: 16375980
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of drug-resistance-associated mutations in antiretroviral drug-naive Zambians infected with subtype C HIV-1.
Handema R; Terunuma H; Kasolo F; Kasai H; Sichone M; Yamashita A; Deng X; Mulundu G; Ichiyama K; Munkanta M; Yokota T; Wakasugi N; Tezuka F; Yamamoto N; Ito M
AIDS Res Hum Retroviruses; 2003 Feb; 19(2):151-60. PubMed ID: 12643279
[TBL] [Abstract][Full Text] [Related]
18. Redistribution of human immunodeficiency virus type 1 variants resistant to protease inhibitors after a protease inhibitor-sparing regimen.
Gianotti N; Seminari E; Lazzarin A; Boeri E; Clementi M; Danise A; Salpietro S; Fusetti G; Castagna A
AIDS Res Hum Retroviruses; 2005 Jun; 21(6):545-54. PubMed ID: 15989459
[TBL] [Abstract][Full Text] [Related]
19. Rapid and sensitive oligonucleotide ligation assay for detection of mutations in human immunodeficiency virus type 1 associated with high-level resistance to protease inhibitors.
Beck IA; Mahalanabis M; Pepper G; Wright A; Hamilton S; Langston E; Frenkel LM
J Clin Microbiol; 2002 Apr; 40(4):1413-9. PubMed ID: 11923366
[TBL] [Abstract][Full Text] [Related]
20. Longitudinal Detection and Persistence of Minority Drug-Resistant Populations and Their Effect on Salvage Therapy.
Nishizawa M; Matsuda M; Hattori J; Shiino T; Matano T; Heneine W; Johnson JA; Sugiura W
PLoS One; 2015; 10(9):e0135941. PubMed ID: 26360259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
